AxoGen, Inc. (NASDAQ: AXGN) is a medical technology company dedicated to peripheral nerve repair. The company’s portfolio of regenerative medicine products is available in the United States, Canada and several other countries and includes Avance® Nerve Graft, for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard® Nerve Connector, for tensionless repair of severed nerves; and AxoGuard® Nerve Protector, a product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. For more information, visit the company’s website at www.axogeninc.com